In addition, an advantage of gp130F/F mice compared to other GC mouse models (e.g., INS-GAS and Gan) is the short tumor latency of 6 weeks post-birth, coupled with 100% disease penetrance on multiple genetic backgrounds (129Sv, C57BL/6, and BALB/c) (11, 30). This evidence concerns the gene GAN and neoplasm.